Warning! GuruFocus has detected 7 Severe warning signs with SIEN. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Also Trade In: Germany
Current and historical daily P/E ratio for Sientra Inc () from 2014 to May 08 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Sientra stock (SIEN) PE ratio as of May 08 2021 is 0. More Details
Sientra PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Sientra PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
420 South Fairview Avenue, Suite 200, Santa Barbara, CA, USA, 93117
Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands' OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.